Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity.
about
Future perspectives in target-specific immunotherapies of myasthenia gravisMyalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsB cell repertoires in HLA-sensitized kidney transplant candidates undergoing desensitization therapyFc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent CytotoxicityB cells regulate macrophage phenotype and response to chemotherapy in squamous carcinomas.Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximabEfficacy of rituximab in non-paraneoplastic autoimmune retinopathy.De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease.Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein neuropathyBAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) miceMonoclonal antibodies specific for human IgM Fc receptor inhibit ligand-binding activity.Persistence of anti-desmoglein 3 IgG(+) B-cell clones in pemphigus patients over years.Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.Follicular B cells in thyroids of mice with spontaneous autoimmune thyroiditis contribute to disease pathogenesis and are targets of anti-CD20 antibody therapy.Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future.Acquired neuropathies.Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches.Anti-CD20 monoclonal antibodies in multiple sclerosis.Potential importance of B cells in aging and aging-associated neurodegenerative diseases.Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune DiseasesAutoantibodies in chronic inflammatory neuropathies: diagnostic and therapeutic implications.Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies.Functional characterization of reappearing B cells after anti-CD20 treatment of CNS autoimmune disease
P2860
Q26776225-34BB421E-9E8E-4851-A420-613C2C77932AQ26998412-109564E8-138C-480E-965C-B51E2557214AQ28563989-BE809A13-0AA9-47F5-88DB-59341F4D8B17Q33766365-484F0C1B-14E1-4404-B86D-192FF66F5B7BQ33776937-920972FF-E5DA-4CA7-9964-7F8696191640Q33798060-0D8E83CE-51F4-41E2-896D-DB22FBF91AFDQ33909097-DC602D95-5B2C-4014-8322-79B2124E5584Q34112037-A1D50A88-7099-40E1-B251-B99C3E34215CQ34344264-357EDA57-51B7-40C5-B9AC-235282A9A7ACQ34656412-7B3C1667-BD2D-4E84-BD1C-DC1C76489394Q34780213-B63042CE-5EBC-4CCD-958C-71F1E4DA22A7Q34964558-27E73AD8-CF17-40C4-9397-BC8E349536B0Q36484465-463AB565-842A-4E10-A873-4ADD6FF80ACFQ37512037-757B843F-0D9A-4E77-A0FE-BD6C7F6DF279Q38068530-AF4A1243-D51F-49B5-BFDE-FC5F7997EC1EQ38114834-1B6486A4-F52E-4A78-B99A-538014406F44Q38598881-C880DCAD-5523-4F36-B04F-A68A7DBC70ABQ38975695-BFC7621F-2E4C-4311-9C84-8AB6B4498B76Q39084950-301DE703-B49D-43D0-9454-72A795DC6D5AQ39109245-6FA783C4-3D8F-4833-A2DF-A09A42B4FDD6Q39434973-006E22D3-02B1-4364-850F-65681BAE676AQ50197158-C237B08D-8E2A-4B48-A748-B3BE3347B73DQ58758199-2DA33A3D-B0E1-495D-8941-0F6651F48066
P2860
Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Rituximab induces sustained re ...... l nervous system autoimmunity.
@ast
Rituximab induces sustained re ...... l nervous system autoimmunity.
@en
type
label
Rituximab induces sustained re ...... l nervous system autoimmunity.
@ast
Rituximab induces sustained re ...... l nervous system autoimmunity.
@en
prefLabel
Rituximab induces sustained re ...... l nervous system autoimmunity.
@ast
Rituximab induces sustained re ...... l nervous system autoimmunity.
@en
P2093
P2860
P50
P356
P1476
Rituximab induces sustained re ...... al nervous system autoimmunity
@en
P2093
Carol S Leung
Christian Münz
Goran Rakocevic
Hedda Wardemann
Marinos Dalakas
Norbert Goebels
P2860
P304
P356
10.1172/JCI58743
P407
P577
2012-03-19T00:00:00Z